While the incidence of many types of cancer in the United States has decreased in recent years, the incidence of hepatocellular carcinoma, secondary to either hepatitis B or cirrhosis, has been on the rise. And, of the treatment options including resection, ablation and transplantation, what tumor characteristics determine treatment and which patients might benefit most from liver transplant? Dr. Mary Maluccio, director of the liver oncology program at Indiana University Health, discusses the advantages of transplant, the length of time that patients generally wait to receive a donor liver and the criteria for donor organs. Hosted by Dr. Aaron Carroll.
Transplant & Treatment Options for Patients with Hepatocellular Carcinoma

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
While the incidence of many types of cancer in the United States has decreased in recent years, the incidence of hepatocellular carcinoma, secondary to either hepatitis B or cirrhosis, has been on the rise. And, of the treatment options including resection, ablation and transplantation, what tumor characteristics determine treatment and which patients might benefit most from liver transplant? Dr. Mary Maluccio, director of the liver oncology program at Indiana University Health, discusses the advantages of transplant, the length of time that patients generally wait to receive a donor liver and the criteria for donor organs. Hosted by Dr. Aaron Carroll.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Pulmonary Hypertension Management: Practice Trends and Updates
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
Reducing the Risk of Postpartum Depression Through Sleep Interventions
Improving the IUD Experience: Evidence-Based Pain Management Approaches
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?